The FTC put pharma giants on notice for deceptive marketing claims. But does it actually have the authority?

t
Be on the lookout, healthcare industry. The Federal Trade Commission (FTC) is putting companies on notice for deceptive marketing claims.

Earlier this month, Johnson & Johnson and Pfizer were among hundreds of health companies to receive a threatening message from the FTC that they could face stiff penalties for running ads with baseless product claims. However, the agency may have exaggerated its penalty authority, legal experts say.